Ask AI
IMforte Subtype and QTWiST Analyses
IMforte Phase III Trial: Transcriptomic and Q-TWiST Analyses of Lurbinectedin + Atezolizumab Maintenance Therapy in Extensive-Stage SCLC

Released: June 22, 2026

Activity

Progress
1
Course Completed
Activity Information

Released: June 22, 2026